Avacta enters research collaboration with OncoSec
Avacta Group announced on Monday that it and OncoSec Medical Incorporated have entered into a research collaboration to combine Avacta's ‘Affimer’ protein platform with OncoSec's gene delivery technology ‘ImmunoPulse’.